RevoDx HPV 26 Screening Kit
Human papillomavirus (HPV) infections are very common and viral DNA can be detected from skin, oral and anogenital samples from all human populations. Currently, over 200 types of HPV have been fully characterized and predominantly assigned into three genera: Alphapapillomavirus, Betapapillomavirus and Gammapapillomavirus. Among the 65 HPV types belonging to Alphapapillomavirus (Alpha-HPV types), a limited set of viruses are considered oncogenic and associated with the development of cervical cancer and its precursor lesions. The oncogenic HPVs causing essentially all cervical cancers are phylogenetically clustered in one clade composed of species Alpha-5, Alpha-6, Alpha-7, Alpha-9 and Alpha-11.
Intended Use
RevoDx HPV 26 Screening Kit is a real-time PCR test intended for the qualitative detection of nucleic acids from 24 high-risk and 2 low-risk Human Papillomavirus (HPV) DNA in one tube.
The following HPV genotypes are detected by RevoDx HPV 26 Screening Kit:
24 high-risk HPV DNA/span> |
HPV 16, 18, 26, 30, 31, 33, 34, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 67, 68, 69, 70, 73, 82 and 97 |
2 low-risk HPV DNA |
HPV 6 and 11 |
Features
- Multiple targets in single tube
- Ready-to-use kit
- Human RNase P as an internal control
- CE-IVD marked
- Assay duration: 60 mins
- The Limit of Detection (LoD) value is 48 IU/mL
- No cross-reactivity with the potential cross-reactive markers shown using both in silico analysis and wet testing.
Product Name |
Package |
Cat. No. |
RevoDx HPV 26 Screening Kit |
100 tests |
IP202222-100 |